Search research articles
Contact Us
Filters
Showing results (511-520 of 569) with videos related to
Page
of 57
Sort By:
Alimentary Pharmacology & Therapeutics
|
May 4, 2018
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma
M Persico, A Aglitti, A Aghemo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 26, 2023
MRTX-500 Phase 2 Trial: Sitravatinib With Nivolumab in Patients With Nonsquamous NSCLC Progressing On or After Checkpoint Inhibitor Therapy or Chemotherapy
Kai He, David Berz, Shirish M Gadgeel, et al.
Journal of Viral Hepatitis
|
October 15, 2014
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program
S Bruno, S Bollani, A L Zignego, et al.
Journal of the American College of Nutrition
|
September 11, 2013
Whey protein supplementation during resistance training augments lean body mass
Jeff S Volek, Brittanie M Volk, Ana L Gómez, et al.
Alimentary Pharmacology & Therapeutics
|
October 30, 2016
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon
S Petta, G Cabibbo, M Barbara, et al.
JCI Insight
|
March 14, 2023
Plasmin and plasminogen prevent sepsis severity by reducing neutrophil extracellular traps and systemic inflammation
Juliana P Vago, Isabella Zaidan, Luiza O Perucci, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 6, 2019
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020
David S Ettinger, Douglas E Wood, Charu Aggarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 5, 2021
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021
David S Ettinger, Douglas E Wood, Dara L Aisner, et al.
The Journal of Antimicrobial Chemotherapy
|
December 19, 2015
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels
V C Di Maio, V Cento, D Di Paolo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 6, 2023
Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
David S Ettinger, Douglas E Wood, James Stevenson, et al.
Page
of 57
Search research articles
Search
Showing results (511-520 of 569) with videos related to
Sort By:
Page
of 57
Alimentary Pharmacology & Therapeutics
|
May 4, 2018
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma
M Persico, A Aglitti, A Aghemo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 26, 2023
MRTX-500 Phase 2 Trial: Sitravatinib With Nivolumab in Patients With Nonsquamous NSCLC Progressing On or After Checkpoint Inhibitor Therapy or Chemotherapy
Kai He, David Berz, Shirish M Gadgeel, et al.
Journal of Viral Hepatitis
|
October 15, 2014
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program
S Bruno, S Bollani, A L Zignego, et al.
Journal of the American College of Nutrition
|
September 11, 2013
Whey protein supplementation during resistance training augments lean body mass
Jeff S Volek, Brittanie M Volk, Ana L Gómez, et al.
Alimentary Pharmacology & Therapeutics
|
October 30, 2016
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon
S Petta, G Cabibbo, M Barbara, et al.
JCI Insight
|
March 14, 2023
Plasmin and plasminogen prevent sepsis severity by reducing neutrophil extracellular traps and systemic inflammation
Juliana P Vago, Isabella Zaidan, Luiza O Perucci, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 6, 2019
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020
David S Ettinger, Douglas E Wood, Charu Aggarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 5, 2021
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021
David S Ettinger, Douglas E Wood, Dara L Aisner, et al.
The Journal of Antimicrobial Chemotherapy
|
December 19, 2015
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels
V C Di Maio, V Cento, D Di Paolo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 6, 2023
Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
David S Ettinger, Douglas E Wood, James Stevenson, et al.
Page
of 57